{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Apoptosis", "Combretastatin A-4", "Glioblastoma multiforme", "Invasion", "Metastasis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37838642", "DateCompleted": {"Year": "2023", "Month": "10", "Day": "30"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "10", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.1007/s12032-023-02197-1"], "Journal": {"ISSN": "1559-131X", "JournalIssue": {"Volume": "40", "Issue": "11", "PubDate": {"Year": "2023", "Month": "Oct", "Day": "14"}}, "Title": "Medical oncology (Northwood, London, England)", "ISOAbbreviation": "Med Oncol"}, "ArticleTitle": "Combretastatin A-4 suppresses the invasive and metastatic behavior of glioma cells and induces apoptosis in them: in-vitro study.", "Pagination": {"StartPage": "331", "MedlinePgn": "331"}, "Abstract": {"AbstractText": ["The most common primary brain\u00a0malignancy, glioblastoma multiforme, is tremendously resistant to conventional\u00a0treatments\u00a0due to its potency for metastasis to surrounding brain tissue. Temozolomide is a chemotherapeutic agent that currently is administrated during the treatment procedure. Studies have attempted to investigate new agents with higher effectiveness and fewer side effects. Combretastatin A-4 (CA-4), a natural compound derived from Combretum caffrum, has been recently considered for its potent antitumor activities in a wide variety of preclinical solid tumor models. Our findings have shown that CA-4 exerts potent anti-proliferative and apoptotic effects on glioma cells, and ROS generation may be involved in these cellular events. CA-4 has imposed G2 arrest in U-87 cells. We also observed that CA-4 significantly reduced the migration and invasion capability of U-87 cells. Furthermore, the gene expression and enzyme activity of MMP-2 and MMP-9 were significantly inhibited in the presence of CA-4. We also observed a considerable decrease in PI3K and Akt protein expression following treatment with CA-4. In conclusion, our findings showed significant apoptogenic and anti-metastatic effects of CA-4 on glioma cells and also suggested that the PI3K/Akt/MMP-2/-9 and also ROS pathway might play roles in these cellular events."], "CopyrightInformation": "\u00a9 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Roshan", "ForeName": "Mostafa Karimi", "Initials": "MK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Afshari", "ForeName": "Amir R", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran."}], "LastName": "Mirzavi", "ForeName": "Farshad", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Mousavi", "ForeName": "Seyed Hadi", "Initials": "SH"}, {"Identifier": ["0000-0003-2145-125X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. SoukhtanlooM@mums.ac.ir."}, {"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. SoukhtanlooM@mums.ac.ir."}], "LastName": "Soukhtanloo", "ForeName": "Mohammad", "Initials": "M"}], "GrantList": [{"GrantID": "970217", "Agency": "Mashhad University of Medical Sciences", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Med Oncol", "NlmUniqueID": "9435512", "ISSNLinking": "1357-0560"}, "ChemicalList": [{"RegistryNumber": "EC 3.4.24.24", "NameOfSubstance": "Matrix Metalloproteinase 2"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "EC 2.7.1.-", "NameOfSubstance": "Phosphatidylinositol 3-Kinases"}, {"RegistryNumber": "I5590ES2QZ", "NameOfSubstance": "fosbretabulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Matrix Metalloproteinase 2"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinases"}, {"QualifierName": [], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["pathology"], "DescriptorName": "Glioma"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["pathology"], "DescriptorName": "Brain Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Dimov I, et al. Glioblastoma multiforme stem cells. ScientificWorldJournal. 2011;11:930\u201358.", "ArticleIdList": ["21516289", "5719986", "10.1100/tsw.2011.42"]}, {"Citation": "Maghrouni A, et al. Targeting the PD-1/PD-L1 pathway in glioblastoma multiforme: Preclinical evidence and clinical interventions. Int Immunopharmacol. 2021;93: 107403.", "ArticleIdList": ["33581502", "10.1016/j.intimp.2021.107403"]}, {"Citation": "Afshari AR, et al. Auraptene-induced cytotoxicity mechanisms in human malignant glioblastoma (U87) cells: role of reactive oxygen species (ROS). EXCLI J. 2019;18:576\u201390.", "ArticleIdList": ["31611741", "6785765"]}, {"Citation": "Afshari AR, et al. Effects of statins on brain tumors: a review. Semin Cancer Biol. 2020;73:116.", "ArticleIdList": ["32814114", "10.1016/j.semcancer.2020.08.002"]}, {"Citation": "Afshari AR, Mollazadeh H, Sahebkar A. Minocycline in treating glioblastoma multiforme: far beyond a conventional antibiotic. J Oncol. 2020;2020:8659802.", "ArticleIdList": ["33014057", "7519463", "10.1155/2020/8659802"]}, {"Citation": "Soukhtanloo M, et al. Natural products as promising targets in glioblastoma multiforme: a focus on NF-\u03baB signaling pathway. Pharmacol Rep. 2020;72(2):285\u201395.", "ArticleIdList": ["32152926", "10.1007/s43440-020-00081-7"]}, {"Citation": "Afshari AR, et al. Protective role of natural products in glioblastoma multiforme: a focus on nitric oxide pathway. Curr Med Chem. 2021;28(2):377\u2013400.", "ArticleIdList": ["32000638", "10.2174/0929867327666200130104757"]}, {"Citation": "Ng QS, et al. Tumor antivascular effects of radiotherapy combined with combretastatin a4 phosphate in human non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;67(5):1375\u201380.", "ArticleIdList": ["17275203", "10.1016/j.ijrobp.2006.11.028"]}, {"Citation": "Pettit GR, et al. Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs. Anticancer Drug Des. 1995;10(4):299\u2013309.", "ArticleIdList": ["7786396"]}, {"Citation": "Zhao D, et al. Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI. Faseb j. 2008;22(7):2445\u201351.", "ArticleIdList": ["18263704", "10.1096/fj.07-103713"]}, {"Citation": "Nik ME, et al. Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment. J Cell Physiol. 2019;234:14721.", "ArticleIdList": ["30697744", "10.1002/jcp.28230"]}, {"Citation": "Qin H, et al. PI3Kgamma inhibitor attenuates immunosuppressive effect of Poly(l-Glutamic Acid)-combretastatin A4 conjugate in metastatic breast cancer. Adv Sci (Weinh). 2019;6(12):1900327.", "ArticleIdList": ["31380170", "10.1002/advs.201900327"]}, {"Citation": "Zhang C, et al. Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway. Cell Physiol Biochem. 2015;35(2):419\u201332.", "ArticleIdList": ["25613036", "10.1159/000369707"]}, {"Citation": "Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol. 1999;43(Suppl):S42-51.", "ArticleIdList": ["10357558", "10.1007/s002800051097"]}, {"Citation": "Zhang S, et al. Autophagy- and MMP-2/9-mediated reduction and redistribution of ZO-1 contribute to hyperglycemia-increased blood-brain barrier permeability during early reperfusion in stroke. Neuroscience. 2018;377:126\u201337.", "ArticleIdList": ["29524637", "10.1016/j.neuroscience.2018.02.035"]}, {"Citation": "Liu Y, et al. Fucoxanthin activates apoptosis via inhibition of PI3K/Akt/mTOR pathway and suppresses invasion and migration by restriction of p38-MMP-2/9 pathway in human glioblastoma cells. Neurochem Res. 2016;41(10):2728\u201351.", "ArticleIdList": ["27394418", "10.1007/s11064-016-1989-7"]}, {"Citation": "Chen G, et al. Plumbagin suppresses the migration and invasion of glioma cells via downregulation of MMP-2/9 expression and inaction of PI3K/Akt signaling pathway in vitro. J Pharmacol Sci. 2017;134(1):59\u201367.", "ArticleIdList": ["28506595", "10.1016/j.jphs.2017.04.003"]}, {"Citation": "Rodriguez LG, Wu X, Guan JL. Wound-healing assay. Methods Mol Biol. 2005;294:23\u20139.", "ArticleIdList": ["15576902"]}, {"Citation": "Vandooren J, et al. Zymography methods for visualizing hydrolytic enzymes. Nat Methods. 2013;10(3):211\u201320.", "ArticleIdList": ["23443633", "10.1038/nmeth.2371"]}, {"Citation": "Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138.", "ArticleIdList": ["11846609", "10.1006/meth.2001.1262"]}, {"Citation": "Mohtashami E, et al. The current state of potential therapeutic modalities for glioblastoma multiforme: a clinical review. Curr Drug Metab. 2020;21(8):564\u201378.", "ArticleIdList": ["32664839", "10.2174/1389200221666200714101038"]}, {"Citation": "Sherbet GV. Combretastatin analogues in cancer biology: A prospective view. J Cell Biochem. 2020;121(3):2127\u201338.", "ArticleIdList": ["31774211", "10.1002/jcb.29342"]}, {"Citation": "Nathan P, et al. Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer. Clin Cancer Res. 2012;18(12):3428\u201339.", "ArticleIdList": ["22645052", "10.1158/1078-0432.CCR-11-3376"]}, {"Citation": "Kamal A, et al. Synthesis and biological evaluation of arylcinnamide linked combretastatin-A4 hybrids as tubulin polymerization inhibitors and apoptosis inducing agents. Bioorg Med Chem Lett. 2016;26(12):2957\u201364.", "ArticleIdList": ["27161282", "10.1016/j.bmcl.2016.03.049"]}, {"Citation": "Yan J, et al. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells. Biochem Pharmacol. 2015;97(1):51\u201361.", "ArticleIdList": ["26212540", "10.1016/j.bcp.2015.07.008"]}, {"Citation": "Tian J, et al. Scoulerine promotes cell viability reduction and apoptosis by activating ROS-dependent endoplasmic reticulum stress in colorectal cancer cells. Chem Biol Interact. 2020;327: 109184.", "ArticleIdList": ["32590070", "10.1016/j.cbi.2020.109184"]}, {"Citation": "Kanthou C, et al. The tubulin-binding agent combretastatin A-4-phosphate arrests endothelial cells in mitosis and induces mitotic cell death. Am J Pathol. 2004;165(4):1401\u201311.", "ArticleIdList": ["15466404", "3118836", "10.1016/S0002-9440(10)63398-6"]}, {"Citation": "Patterson JC, et al. ROS and oxidative stress are elevated in mitosis during asynchronous cell cycle progression and are exacerbated by mitotic arrest. Cell Syst. 2019;8(2):163-167.e2.", "ArticleIdList": ["30797774", "6688173", "10.1016/j.cels.2019.01.005"]}, {"Citation": "Karimi Roshan M, et al. Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process. Biochimie. 2019;165:229\u201334.", "ArticleIdList": ["31401189", "10.1016/j.biochi.2019.08.003"]}, {"Citation": "Jalili-Nik M, et al. Cytotoxic effects of ferula latisecta on human glioma U87 cells. Drug Res (Stuttg). 2019;69(12):665\u201370.", "ArticleIdList": ["31499542", "10.1055/a-0986-6543"]}, {"Citation": "Choe G, et al. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin Cancer Res. 2002;8(9):2894\u2013901.", "ArticleIdList": ["12231534"]}, {"Citation": "Wang C, et al. Effect of matrix metalloproteinase-mediated matrix degradation on glioblastoma cell behavior in 3D PEG-based hydrogels. J Biomed Mater Res A. 2017;105(3):770\u20138.", "ArticleIdList": ["27770562", "10.1002/jbm.a.35947"]}, {"Citation": "Sun LC, et al. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. Cancer Lett. 2007;246(1\u20132):157\u201366.", "ArticleIdList": ["16644105", "10.1016/j.canlet.2006.02.016"]}, {"Citation": "Mirzavi F, et al. Pegylated liposomal encapsulation improves the antitumor efficacy of combretastatin A4 in murine 4T1 triple-negative breast cancer model. Int J Pharm. 2022;613: 121396.", "ArticleIdList": ["34942328", "10.1016/j.ijpharm.2021.121396"]}, {"Citation": "Gloushankova NA, Rubtsova SN, Zhitnyak IY. Cadherin-mediated cell-cell interactions in normal and cancer cells. Tissue Barriers. 2017;5(3): e1356900.", "ArticleIdList": ["28783415", "5571778", "10.1080/21688370.2017.1356900"]}, {"Citation": "Lu Y, et al. Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate. 2006;66(12):1311\u20138.", "ArticleIdList": ["16705739", "10.1002/pros.20464"]}, {"Citation": "Dagouassat M, et al. Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells. Int J Cancer. 2010;126(5):1095\u2013108.", "ArticleIdList": ["19642141", "10.1002/ijc.24800"]}, {"Citation": "Dwyer RM, et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res. 2007;13(17):5020\u20137.", "ArticleIdList": ["17785552", "10.1158/1078-0432.CCR-07-0731"]}, {"Citation": "Dwyer J, et al. Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2. PLoS ONE. 2012;7(9): e45562.", "ArticleIdList": ["23029099", "3447807", "10.1371/journal.pone.0045562"]}, {"Citation": "Chen JS, et al. Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. Hepatol Res. 2009;39(2):177\u201386.", "ArticleIdList": ["19208038", "10.1111/j.1872-034X.2008.00449.x"]}, {"Citation": "Li X, et al. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma. Oncotarget. 2016;7(22):33440\u201350.", "ArticleIdList": ["26967052", "5078108", "10.18632/oncotarget.7961"]}, {"Citation": "Wang H, et al. Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. Lab Invest. 2004;84(8):941\u201351.", "ArticleIdList": ["15184909", "10.1038/labinvest.3700123"]}, {"Citation": "Sonoda Y, et al. Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res. 2001;61(18):6674\u20138.", "ArticleIdList": ["11559533"]}, {"Citation": "Kapitonov D, et al. Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts. Cancer Res. 2009;69(17):6915\u201323.", "ArticleIdList": ["19723667", "2752891", "10.1158/0008-5472.CAN-09-0664"]}, {"Citation": "Jo H, Loison F, Luo HR. Microtubule dynamics regulates Akt signaling via dynactin p150. Cell Signal. 2014;26(8):1707\u201316.", "ArticleIdList": ["24726838", "10.1016/j.cellsig.2014.04.007"]}, {"Citation": "Liang W, et al. Combretastatin A4 regulates proliferation, migration, invasion, and apoptosis of thyroid cancer cells via PI3K/Akt signaling pathway. Med Sci Monit. 2016;22:4911\u20137.", "ArticleIdList": ["27966519", "5179240", "10.12659/MSM.898545"]}, {"Citation": "Barber AG, et al. PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer. Cancer Med. 2015;4(8):1258\u201371.", "ArticleIdList": ["26033689", "4559037", "10.1002/cam4.463"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "8", "Day": "10"}, {"Year": "2023", "Month": "9", "Day": "19"}, {"Year": "2023", "Month": "10", "Day": "30", "Hour": "6", "Minute": "46"}, {"Year": "2023", "Month": "10", "Day": "15", "Hour": "5", "Minute": "46"}, {"Year": "2023", "Month": "10", "Day": "14", "Hour": "23", "Minute": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["37838642", "10.1007/s12032-023-02197-1", "10.1007/s12032-023-02197-1"]}}], "PubmedBookArticle": []}